Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

651 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Significant differences in access to tests and treatments for multiple myeloma between public and private systems in Latin America. Results of a Latin American survey. GELAMM (Grupo de Estudio Latino Americano de Mieloma Múltiple).
Riva E, Schütz N, Peña C, Ruiz-Argüelles G, Hopkins CR, Bove V, Villano F, Andino L, Suárez L, Martínez H, Navarro J, López-Vidal H, Da Costa O, Pineda MR, Rubio Y, Ramirez J, Choque J, Fantl D. Riva E, et al. Ann Hematol. 2020 May;99(5):1025-1030. doi: 10.1007/s00277-020-03983-x. Epub 2020 Mar 10. Ann Hematol. 2020. PMID: 32157420 Clinical Trial.
Second primary malignancies in multiple myeloma: an overview and IMWG consensus.
Musto P, Anderson KC, Attal M, Richardson PG, Badros A, Hou J, Comenzo R, Du J, Durie BGM, San Miguel J, Einsele H, Chen WM, Garderet L, Pietrantuono G, Hillengass J, Kyle RA, Moreau P, Lahuerta JJ, Landgren O, Ludwig H, Larocca A, Mahindra A, Cavo M, Mazumder A, McCarthy PL, Nouel A, Rajkumar SV, Reiman A, Riva E, Sezer O, Terpos E, Turesson I, Usmani S, Weiss BM, Palumbo A; International Myeloma Working Group. Musto P, et al. Among authors: riva e. Ann Oncol. 2017 Feb 1;28(2):228-245. doi: 10.1093/annonc/mdw606. Ann Oncol. 2017. PMID: 27864218 Free article. Review.
Digital Ischemia as an Unusual Manifestation of Hodgkin's Lymphoma.
Villano F, Peixoto A, Riva E, Di Matteo C, Díaz L. Villano F, et al. Among authors: riva e. Case Rep Hematol. 2018 Aug 19;2018:1980749. doi: 10.1155/2018/1980749. eCollection 2018. Case Rep Hematol. 2018. PMID: 30210881 Free PMC article.
Analysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American Countries.
Pessoa de Magalhães Filho RJ, Crusoe E, Riva E, Bujan W, Conte G, Navarro Cabrera JR, Garcia DK, Vega GQ, Macias J, Oliveros Alvear JW, Royg M, Neves LA, Lopez Dopico JL, Espino G, Ortiz DR, Socarra Z, Fantl D, Ruiz-Arguelles GJ, Maiolino A, Hungria VTM, Harousseau JL, Durie B. Pessoa de Magalhães Filho RJ, et al. Among authors: riva e. Clin Lymphoma Myeloma Leuk. 2019 Jan;19(1):e43-e50. doi: 10.1016/j.clml.2018.08.005. Epub 2018 Aug 29. Clin Lymphoma Myeloma Leuk. 2019. PMID: 30297171
Epidemiological and clinical characteristics and outcome of monoclonal gammopathy of renal significance-related lesions in Latin America.
Peña C, Schutz NP, Riva E, Valjalo R, Majlis A, López-Vidal H, Lois V, Zamora D, Ochoa P, Shanley C, Gonzalez JT, Fantl D, Correa G, Ramirez J, Mur P, Silva G, Verri V, Rojas C, Escobar K, Glavic G, Méndez GP; Grupo de estudio latinoamericano de mieloma múltiple (GELAMM). Peña C, et al. Among authors: riva e. Nephrology (Carlton). 2020 Jun;25(6):442-449. doi: 10.1111/nep.13685. Epub 2019 Dec 19. Nephrology (Carlton). 2020. PMID: 31825549
Comparison of two different anti-infectious approaches after high-dose chemotherapy and autologous stem cell transplantation for hematologic malignancies in a 12-year period in British Hospital, Uruguay.
Oliver AC, Riva E, Mosquera R, Galeano S, Pierri S, Bello L, Caneiro A, Gai R, Miller A, Muxi P. Oliver AC, et al. Among authors: riva e. Ann Hematol. 2020 Apr;99(4):877-884. doi: 10.1007/s00277-020-03947-1. Epub 2020 Feb 15. Ann Hematol. 2020. PMID: 32062742
Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study.
Peña C, Riva E, Schutz N, Tarín-Arzaga L, Martínez-Cordero H, Bove V, Osorio R, Chandía M, Beltrán C, Schulz J, Cardemil D, Contreras C, Vergara CG, Donoso J, Espinoza M, La Rocca G, López-Vidal H, León P, Rojas Hopkins C, Soto P, Aranda S, Torres V, Roa M, Ochoa P, Duarte PJ, Remaggi G, Yantorno S, Corzo A, Zabaljauregui S, Shanley C, Lopresti S, Orlando S, Verri V, Quiroga L, García C, Fernández V, Ramirez J, Molina A, Pacheco M, Mite A, Reyes I, Sabando B, Ramírez F, Sossa C, Abello V, Idrobo H, Galvez Cardenas KM, Saavedra D, Quintero G, Gazitúa R, Gaviria L, Gomez R, Osuna M, Henao-Uribe A, Cantú-Martínez O, Gómez-Almaguer D, García-Navarrete YI, Cruz-Mora A, Cantero-Fortiz Y, Ruiz-Argüelles GJ, Fantl D. Peña C, et al. Among authors: riva e. Leuk Lymphoma. 2020 Dec;61(13):3112-3119. doi: 10.1080/10428194.2020.1804558. Epub 2020 Aug 26. Leuk Lymphoma. 2020. PMID: 32844699
651 results